4 results on '"gamma-glutamyl-transferase"'
Search Results
2. Gamma-glutamyl-transferase is associated with incident hip fractures in women and men ≥ 50 years: a large population-based cohort study.
- Author
-
Brozek, W., Ulmer, H., Pompella, A., Nagel, G., Leiherer, A., Preyer, O., Concin, H., and Zitt, E.
- Subjects
- *
GAMMA-glutamyltransferase , *AGE distribution , *HIP fractures , *RISK assessment , *SEX distribution , *LONGITUDINAL method , *DISEASE risk factors - Abstract
Summary: The association of serum gamma-glutamyl-transferase (GGT) with hip fracture risk has not been examined in women and men ≥ 50 years. We show that elevated GGT was associated with increased hip fracture risk, particularly in men. GGT could be a candidate serum marker of long-term hip fracture risk in the elderly. Introduction: We herein examined a possible relation between serum levels of GGT and hip fracture risk in women and men aged ≥ 50 years, which has not been investigated before. Methods: In this population-based prospective cohort study, approximately 41,000 women and nearly 33,000 men ≥ 50 years participating in a medical prevention program 1985–2005 in western Austria were followed up for the occurrence of osteoporotic hip fractures during 2003–2013. ICD-10 based discharge diagnoses for hip fracture included S72.0, S72.1, and S72.2 available from all regional hospitals. GGT-related hip fracture risk was ascertained at each participant´s first and last examination during the prevention program. In a subset of 5445 participants, alcohol consumption could be included as a covariate. Results: In men, hip fracture risk rose significantly by 75% and 86% for every tenfold increase of GGT measured at the first and last examination, respectively, and in women, hip fracture risk rose by 22% from the last examination. Elevated GGT (≥ 36 U/l in women, ≥ 56 U/l in men) at the first examination was associated with increased hip fracture risk only in men (HR 1.51, 95% CI 1.25–1.82), and at the last examination in both women (HR 1.14, 95% CI 1.02–1.28) and men (HR 1.61, 95% CI 1.33–1.95). Alcohol consumption had no significant influence on GGT-mediated hip fracture risk in women and men. Conclusions: Our findings identified an association of elevated GGT and hip fracture in women and men ≥ 50 years and suggest GGT as a candidate serum marker of long-term hip fracture risk in an elderly population. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
- Author
-
Adrian, Therese, Hornum, Mads, Knop, Filip Krag, Almdal, Thomas, Rossing, Peter, Lida, Lisa, Heinrich, Niels S., Boer, Vincent Oltman, Marsman, Anouk, Petersen, Esben Thade, Siebner, Hartwig Roman, Feldt-Rasmussen, Bo, Adrian, Therese, Hornum, Mads, Knop, Filip Krag, Almdal, Thomas, Rossing, Peter, Lida, Lisa, Heinrich, Niels S., Boer, Vincent Oltman, Marsman, Anouk, Petersen, Esben Thade, Siebner, Hartwig Roman, and Feldt-Rasmussen, Bo
- Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is suggested as a risk factor for chronic kidney disease (CKD). The incidence of NAFLD is rising globally in parallel to the increasing incidences of obesity and type 2 diabetes. Diabetes remains the leading cause of CKD, but the co-existence of NAFLD, CKD, and type 2 diabetes is not well elucidated. Here, we evaluated the prevalence of NAFLD in patients with type 2 diabetes with and without CKD. Methods: This was a cross-sectional study including 50 patients with type 2 diabetes and CKD stages 3-5 (no dialysis), and 50 patients with type 2 diabetes without CKD. Liver fat content was estimated by proton magnetic resonance spectroscopy and magnetic resonance imaging proton density fat fraction. NAFLD was defined as liver fat fraction >= 5.6% according to guidelines. Results: Mean age was 72 +/- 4.9 years in patients with CKD and 65.9 +/- 7.8 years in patients without CKD (p < 0.0001). Three out of four participants were men. BMI was 28.6 +/- 3.5 kg/m(2) and 27 +/- 4.0 kg/m(2) in patients with and without CKD, respectively (p = 0.0087). NAFLD was identified in 22 (44%) patients with CKD and 19 (38%) patients without CKD (p = 0.6845). Median (IQR) liver fat fraction was 4.7% (3.0-8.5) and 4.1% (2.9-7.7) in patients with and without CKD, respectively (difference in geometric means 5.3%, 95% CI -23; 45, p = 0.7463). Conclusion: These findings do not support any association between NAFLD and CKD (stages 3-5) in patients with type 2 diabetes.
- Published
- 2023
4. Liver pathology and biochemistry in patients with mutations in <scp>TRIM37</scp> gene (Mulibrey nanism)
- Author
-
Johanna Sivunen, Susann Karlberg, Reetta Kivisaari, Jouko Lohi, Niklas Karlberg, Eero Jokinen, Taisto Sarkola, Timo Jahnukainen, Marita Lipsanen‐Nyman, Hannu Jalanko, HUS Children and Adolescents, Children's Hospital, Faculty of Medicine, HUS Medical Imaging Center, Department of Diagnostics and Therapeutics, HUSLAB, Department of Pathology, Lastentautien yksikkö, and Clinicum
- Subjects
Adult ,COILED-COIL PROTEIN ,Adolescent ,liver cirrhosis ,Ubiquitin-Protein Ligases ,GAMMA-GLUTAMYL-TRANSFERASE ,congestive hepatopathy ,DISEASE ,KNOCKDOWN ,Tripartite Motif Proteins ,Young Adult ,FIBROSIS ,Humans ,TRIM37 ,Child ,MUL ,Retrospective Studies ,Hepatology ,ABNORMALITIES ,PROLIFERATION ,Infant ,Middle Aged ,DYSFUNCTION ,PREVALENCE ,Cross-Sectional Studies ,3121 General medicine, internal medicine and other clinical medicine ,Child, Preschool ,immunohistochemistry ,Mutation ,HEART-FAILURE ,Elasticity Imaging Techniques ,Mulibrey Nanism ,Biomarkers - Abstract
Background and Aims Mulibrey nanism (MUL) is a multiorgan disease caused by recessive mutations in the TRIM37 gene. Chronic heart failure and hepatopathy are major determinants of prognosis in MUL patients, which prompted us to study liver biochemistry and pathology in a national cohort of MUL patients. Methods Clinical, laboratory and imaging data were collected in a cross-sectional survey and retrospectively from hospital records. Liver histology and immunohistochemistry for 10 biomarkers were assessed. Results Twenty-one MUL patients (age 1-51 years) with tumour suspicion showed moderate congestion, steatosis and fibrosis in liver biopsies and marginally elevated levels of serum GGT, AST, ALT and AST to platelet ratio index (APRI) in 20%-66%. Similarly, GGT, AST, ALT and APRI levels were moderately elevated in 12%-69% of 17 MUL patients prior to pericardiectomy. In a cross-sectional evaluation of 36 MUL outpatients, GGT, total bilirubin and galactose half-life (Gal1/2) correlated with age (r = 0.45, p = .017; r = 0.512, p = .007; r = 0.44, p = .03 respectively). The frequency of clearly abnormal serum values of 15 parameters analysed, however, was low even in patients with signs of restrictive cardiomyopathy. Transient elastography (TE) of the liver revealed elevated levels in 50% of patients with signs of heart failure and TE levels correlated with several biochemistry parameters. Biomarkers of fibrosis, sinusoidal capillarization and hepatocyte metaplasia showed increased expression in autopsy liver samples from 15 MUL patients. Conclusion Liver disease in MUL patients was characterized by sinusoidal dilatation, steatosis and fibrosis with individual progression to cirrhosis and moderate association of histology with cardiac function, liver biochemistry and elastography.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.